0001773751-24-000176.txt : 20240610
0001773751-24-000176.hdr.sgml : 20240610
20240610163657
ACCESSION NUMBER: 0001773751-24-000176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Okupe Oluyemi
CENTRAL INDEX KEY: 0001907056
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 241033280
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST., #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1718051810.xml
FORM 4
X0508
4
2024-06-06
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001907056
Okupe Oluyemi
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
0
1
0
0
Chief Financial Officer
1
Class A Common Stock
2024-06-06
4
M
0
86398
5.01
A
238078
D
Class A Common Stock
2024-06-06
4
M
0
7396
11.53
A
245474
D
Class A Common Stock
2024-06-06
4
S
0
98635
21.4247
D
146839
D
Stock Option (right to buy)
5.01
2024-06-06
4
M
0
86398
0
D
2032-02-23
Class A Common Stock
86398
849913
D
Stock Option (right to buy)
11.53
2024-06-06
4
M
0
7396
0
D
2033-03-01
Class A Common Stock
7396
103532
D
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.14 - $21.725. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
2024-06-10